ATE147630T1 - Schutz gegen schock infolge einer schädigung durch doppelsträngige rna's - Google Patents

Schutz gegen schock infolge einer schädigung durch doppelsträngige rna's

Info

Publication number
ATE147630T1
ATE147630T1 AT90916997T AT90916997T ATE147630T1 AT E147630 T1 ATE147630 T1 AT E147630T1 AT 90916997 T AT90916997 T AT 90916997T AT 90916997 T AT90916997 T AT 90916997T AT E147630 T1 ATE147630 T1 AT E147630T1
Authority
AT
Austria
Prior art keywords
result
protection against
double stranded
damage caused
against shock
Prior art date
Application number
AT90916997T
Other languages
English (en)
Inventor
Leo Einck
Original Assignee
Hem Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Pharma Corp filed Critical Hem Pharma Corp
Application granted granted Critical
Publication of ATE147630T1 publication Critical patent/ATE147630T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT90916997T 1989-10-11 1990-10-09 Schutz gegen schock infolge einer schädigung durch doppelsträngige rna's ATE147630T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41966389A 1989-10-11 1989-10-11
US57452490A 1990-08-28 1990-08-28

Publications (1)

Publication Number Publication Date
ATE147630T1 true ATE147630T1 (de) 1997-02-15

Family

ID=27024574

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90916997T ATE147630T1 (de) 1989-10-11 1990-10-09 Schutz gegen schock infolge einer schädigung durch doppelsträngige rna's

Country Status (12)

Country Link
EP (1) EP0495919B1 (de)
JP (1) JP3150967B2 (de)
CN (1) CN1056421A (de)
AT (1) ATE147630T1 (de)
AU (2) AU6740590A (de)
BR (1) BR9007741A (de)
DE (1) DE69029738T2 (de)
HU (1) HUT65404A (de)
IE (1) IE903622A1 (de)
NZ (1) NZ235636A (de)
TW (1) TW206154B (de)
WO (1) WO1991005560A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4409245B2 (ja) * 2003-10-20 2010-02-03 株式会社荏原製作所 耐食性及び耐摩耗性を有する被覆用合金を用いた装置
EP2046954A2 (de) 2006-07-31 2009-04-15 Curevac GmbH Nukleinsäure der formel (i): gixngn, oder (ii): cixmcn, insbesondere als immunstimulierendes mittel/adjuvans
WO2009030254A1 (en) 2007-09-04 2009-03-12 Curevac Gmbh Complexes of rna and cationic peptides for transfection and for immunostimulation
DK2176408T5 (en) 2008-01-31 2015-12-14 Curevac Gmbh Nucleic acids comprising FORMULA (NuGiXmGnNv) a AND DERIVATIVES AS IMMUNE STIMULATING AGENTS / ADJUVANTS.
WO2010037408A1 (en) 2008-09-30 2010-04-08 Curevac Gmbh Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
US20110053829A1 (en) 2009-09-03 2011-03-03 Curevac Gmbh Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
KR101761388B1 (ko) 2010-07-30 2017-07-25 큐어백 아게 트랜스펙션 및 면역 자극을 위한 이황화-크로스링크된 양이온 성분 및 핵산의 복합체
WO2013113326A1 (en) 2012-01-31 2013-08-08 Curevac Gmbh Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
BR112016003361A2 (pt) 2013-08-21 2017-11-21 Curevac Ag vacina do vírus sincicial respiratório (rsv)
US10369216B2 (en) 2014-04-01 2019-08-06 Curevac Ag Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1916332A1 (de) * 1969-03-29 1970-10-08 Bayer Ag Xenologe Nucleinsaeuren als immunsupressive Wirkstoffe
DE2046506A1 (en) * 1970-09-21 1972-03-23 Brendel, Walter, Prof. Dr.; Seinfeld, Hugo; 8000 München Xenologous nucleic acids as immunosupressors - for extending the survival time of transplantates
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)
IL86863A0 (en) * 1987-07-03 1988-11-30 Nippon Shinyaku Co Ltd Nucleic acid derivatives
AU1820388A (en) * 1987-07-17 1989-01-19 Hem Research, Inc. Double stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles
AU1820588A (en) * 1987-07-17 1989-01-19 Hem Research, Inc. Double-stranded rna correction of abnormalities in circulating immune complexes and monocyte function
IE72103B1 (en) * 1987-08-12 1997-03-12 Hem Res Inc Promotion of host defense by systemic dsRNA treatment
EP0306347B1 (de) * 1987-09-04 1995-05-10 Hem Pharmaceuticals Corp. Diagnose von Mangelzuständen doppelsträngiger RNS

Also Published As

Publication number Publication date
BR9007741A (pt) 1992-08-11
NZ235636A (en) 1997-02-24
DE69029738T2 (de) 1997-08-14
HU9201197D0 (en) 1992-08-28
DE69029738D1 (de) 1997-02-27
IE903622A1 (en) 1991-04-24
TW206154B (de) 1993-05-21
AU6751294A (en) 1994-12-08
EP0495919A4 (en) 1993-03-03
AU678250B2 (en) 1997-05-22
CN1056421A (zh) 1991-11-27
JPH05500960A (ja) 1993-02-25
AU6740590A (en) 1991-05-16
WO1991005560A1 (en) 1991-05-02
HUT65404A (en) 1994-06-28
JP3150967B2 (ja) 2001-03-26
EP0495919A1 (de) 1992-07-29
EP0495919B1 (de) 1997-01-15

Similar Documents

Publication Publication Date Title
Denburg Basophil and mast cell lineages in vitro and in vivo
CO5180590A1 (es) Derivados de camptotecina que tienen actividad anti tumores
CO4410203A1 (es) Formulaciones de analogos de insulina
CY1108211T1 (el) Προφυλακτικη και θεραπευτικη αγωγη των μολυσματικων, αυτοανοσων και αλλεργικων νοσων με ενωσεις βασης μονοσακχαριτη
ATE147630T1 (de) Schutz gegen schock infolge einer schädigung durch doppelsträngige rna's
CA2103458A1 (en) Method and composition to reduce myocardial reperfusion injury
DE69623390D1 (de) Aktive implantierbare medizinische Vorrichtung, insbesondere Herzschrittmacher oder Defibrillator
DK0574394T3 (da) I den humane terapi anvendelige stoffer af polypeptidnatur
FI880961A0 (fi) Synergistisk effekt av lymfokiner och dubbelstraengade rna-sekvenser.
Reuvers et al. Potential use of nitrofurans in radiotherapy
NO963029L (no) Anvendelse av IL-10 for å stimulere cytologisk aktivitet av enkjernete celler i perifert blod
DK0563085T3 (da) Hidtil ukendte præparater
WO1999024077A3 (en) Compositions and methods for targeted delivery of biologically-active factors
IL172035A0 (en) Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window
PH27214A (en) N-2,3-butadienyl tri and tetraaminoalkane derivatives
BR0109928A (pt) Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal
ES2036526T3 (es) Composiciones de interferon.
IE781840L (en) Detecting cancerigenic and anticancerous substances
AR015956A1 (es) Composiciones de citoquinas oromucosales y usos de las mismas
CA2060490A1 (en) Protection from shock subsequent to injury by double-stranded rnas
DE69937797D1 (de) Alpha-emittierende konstrukte sowie deren verwendung
RU2003101855A (ru) Средство, нормализующее структуру и функции органов и тканей, стимулирующее репарирование повреждений, обладающее противовирусной активностью, и способ его получения
EP0668771A4 (de) Behandlung von autoimmunkrankheiten durch hervorrüfen von toleranz in zellen, geweben und organen.
Alagaraja et al. A note on clipping experiments to estimate fish production in culture operations
RU93005453A (ru) Средство повышения зимо-морозостойкости растений

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties